6,678 trials
Hemophilia A
Primary: Difference of Annualized Number of All Bleeds Between On-demand and Prophylaxis Period — 56.00 Bleeds
Chronic Obstructive Pulmonary Disease
Primary: Forced Expiratory Volume in One Second (FEV1) Area Under Curve (AUC) 0-2 — 1.490; 1.453 liters per hour
Thrombocytopenia · Idiopathic Thrombocytopenic Purpura
Primary: Percentage of Participants With Collagen Fibrosis — 0.0; 0.0; 3.4 percentage of participants
Major Depressive Disorder · Dysthymia · Spinal Cord Injuries
Primary: Hamilton Depression Rating Scale-17 — 19.5; 19.4; 9.5; 9.5 units on a scale — p=<.025
Benign Prostatic Hyperplasia
Primary: International Prostate Symptom Score — 11.31 units on a scale
Hypertension
Primary: Forearm Blood Flow — 96; 105 ml/min
Diabetes · Hyperglycemia
Primary: Percent of Participants With a Mean Blood Glucose Concentration of Less Than 70 mg/dL — 28; 31 percentage of participants
Type 2 Diabetes · Hypertension
Primary: Changes in Systolic Blood Pressure During Initial Intralipid Infusion — 23; 13 mmHg
Osteoarthritis
Primary: Change in Brain Gray Matter Volume — -0.34; -0.92 percentage of change
Inguinal Hernia
Primary: Rate of Post-operative Infection
Hypertension
Primary: Sympathetic Nerve Activity — 46; 40; 49; 42 bursts/min
Influenza
Primary: Number of Seroconverted Subjects for Serum H5N1 Haemagglutination-inhibition (HI) Antibodies Against Flu A/Indonesia/5/2005 (H5N1) Vaccine Strain in Prepandrix Group…
Primary Immune Deficiency Disorders · Common Variable Immunodeficiency · X-linked Agammaglobulinemia
Primary: Adverse Events — 2 participants — p=0.01
Anxiety Disorders
Primary: Effect of Alprazolam Versus Placebo on BOLD fMRI During Emotion Processing
Smoking
Primary: Exhaled Carbon Monoxide Concentration — 8.3; 12.7 Parts per million — p=0.12